# High Dose Rate Brachyablation of Primary Liver Lesions

> **NCT02893982** · PHASE1 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **RADIATION:** brachytherapy

## Key facts

- **NCT ID:** NCT02893982
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-09
- **Primary completion:** 2020-03-16
- **Final completion:** 2020-03-16
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study was closed due to poor accrual
- **Last updated:** 2021-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02893982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02893982, "High Dose Rate Brachyablation of Primary Liver Lesions". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02893982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*